Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
Appointed director
Inv. presentation
Auditor change
CC transcript
QUESTCOR PHARMACEUTICALS INC (QCOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/20/2014 8-K Form 8-K - Current report
08/14/2014 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "MALLINCKRODT AND QUESTCOR SHAREHOLDERS APPROVE MALLINCKRODT'S ACQUISITION OF QUESTCOR DUBLIN, IRELAND and ANAHEIM, Calif., Aug. 14, 2014 — Mallinckrodt plc and Questcor Pharmaceuticals, Inc. today jointly announced that all proposals necessary for Mallinckrodt's acquisition of Questcor were approved by Mallinckrodt's and Questcor's shareholders at each company's respective shareholder meeting held today. As previously announced, on April 7, 2014, Mallinckrodt and Questcor entered into a definitive agreement by which Mallinckrodt will acquire Questcor. Under the terms of the transaction, Questcor shareholders will receive $30.00 in cash and 0.897 of a Mallinckrodt ordinary share for each Questcor share. Mallinckrodt expects to close the transaction later today and subsequently issue a press..."
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 425 Form 425 - Prospectuses and communications, business combinations
08/11/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/07/2014 425 Form 425 - Prospectuses and communications, business combinations
08/05/2014 425 Form 425 - Prospectuses and communications, business combinations
07/30/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 8-K Other Events
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/29/2014 425 Form 425 - Prospectuses and communications, business combinations
07/28/2014 425 Form 425 - Prospectuses and communications, business combinations
07/25/2014 8-K Quarterly results
Docs: "Questcor Reports Record Second Quarter Financial Results"
07/24/2014 10-Q Quarterly Report for the period ended June 30, 2014
07/14/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/14/2014 425 Form 425 - Prospectuses and communications, business combinations
07/14/2014 425 Form 425 - Prospectuses and communications, business combinations
07/11/2014 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
07/10/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Revisions, where applicable, to the 2013 Form 10-K include: • Part I, Item 1. Business • Part I, Item 1A. Risk Factors • Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations"
07/10/2014 425 Form 425 - Prospectuses and communications, business combinations
06/11/2014 SC 13G MORGAN STANLEY reports a 5% stake in QUESTCOR PHARMACEUTICALS INC
05/15/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/12/2014 SC 13G/A FMR LLC reports a 2% stake in QUESTCOR PHARMACEUTICALS INC
05/05/2014 8-K Quarterly results
Docs: "Questcor Reports First Quarter Financial Results"
05/02/2014 SC 13G ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.3% stake in QUESTCOR PHARMACEUTICALS, INC.
04/30/2014 10-K/A Annual Report for the period ended December 31, 2013 [amend]
04/29/2014 10-Q Quarterly Report for the period ended March 31, 2014
04/07/2014 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Mallinckrodt plc, Quincy Merger Sub, Inc. and Questcor Pharmaceuticals, Inc. (schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K)",
"MALLINCKRODT PHARMACEUTICALS AND QUESTCOR PHARMACEUTICALS ENTER INTO DEFINITIVE MERGER AGREEMENT UNDER WHICH MALLINCKRODT WILL ACQUIRE QUESTCOR FOR APPROXIMATELY $5.6 BILLION, CREATING A DIVERSIFIED, HIGH-GROWTH SPECIALTY PHARMACEUTICALS COMPANY"
03/03/2014 8-K Quarterly results, Conference call transcript
Docs: "Questcor Reports Fourth Quarter and Full Year 2013 Financial Results - Fourth Quarter Net Sales $243 Million; Increase 51% Year-over-Year - - Fourth Quarter GAAP EPS of $1.44, Non-GAAP EPS of $1.67 up 53% -",
"Transcript of conference call held on February 25, 2014",
"Presentation slides used during conference call held on February 25, 2014"
03/03/2014 8-K Regulation FD Disclosure
02/26/2014 10-K Annual Report for the period ended December 31, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy